Today's star - Dr. Hildo Lantermans
Dr. Hildo Lantermans is a postdoctoral researcher in Pediatric Nephrology at Amsterdam UMC, studying urine derived kidney progenitor cells and their application for cell therapy and disease modeling. Furthermore, he studies disrupted kidney development in children with congenital anomalies.
How does Dr. Hildo Lantermans share his knowledge and findings other than through articles, posters, and presentations?
"More informal discussions with peers, funding agencies and industry allows us to spotlight our research lines and form new collaborations. Attending interdisciplinary meetings as well as discussing with patients, patient associations and the general public let us communicate our research to a diverse non-specialist audience. Lastly we use the various communication channels of Amsterdam UMC to highlight our scientific findings to the general public."
How does the research of Dr. Hildo Lantermans contribute to the health of current and future generations?
"Kidney disease is a major societal burden by reducing quality of life and leading to premature death and disability. We want to use urine derived kidney progenitor cells for regenerative therapy, as kidneys have limited intrinsic regenerative capacity. Therefore we are developing this into a well-defined and clinical grade product. Furthermore, advancing our
understanding of incorrect kidney development could help us improve kidney function in affected patients."
Dr. Hildo Lantermans for Postdoc Appreciation Week-NL Photo credits: Martijn Gijsbertsen.